Five Prime Therapeutics, Inc.

In Vivo's editors, along with experts from the Informa Pharma Intelligence team, have selected our top five picks for the most significant M&A, alliance and financing deals of 2021. Vote now in the p

Lupin Limited is lining up an oncology pipeline using therapeutic approaches ranging from better-known stimulator of interferon genes (STING) agonists to a lesser-used one involving protein coding ge

The biggest question going into the J.P. Morgan Healthcare Conference every year is which big company is going to announce a large acquisition. Amgen, Inc. CEO Robert Bradway’s answer on 11 January

The biopharmaceutical sector did not relax in 2021. Biotechs raised record sums in private financing rounds and emerging companies went public with huge IPOs, while larger pharma players announced sev